STOCK TITAN

Ayr Wellness (AYRWF) Stock Price, News & Analysis

AYRWF OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
164 251 sessions, July 24, 2025 to July 24, 2026
Largest daily move
+225% close of December 4, 2025
1-year change
-97.9% closing prices, July 24, 2025 to July 24, 2026
1-month change
-78.4% closing prices, June 23, 2026 to July 24, 2026

Company Description

AYR Wellness Inc. (AYRWF) is described in public disclosures and news releases as a vertically integrated U.S. multi-state cannabis operator. The company is associated with the medicinal and botanical manufacturing industry within the broader manufacturing sector, and its securities trade over-the-counter under the symbol AYRWF and on the CSE under AYR.A. According to recent company communications, AYR operates cannabis businesses in multiple U.S. states and has focused on core operations in Florida, New Jersey, Nevada, Ohio, Massachusetts, Pennsylvania and Virginia.

Business focus and operations

AYR Wellness and its affiliates are repeatedly described as a multi-state cannabis operator, reflecting operations that span cultivation, production and retail activities in the cannabis sector. In Florida, the company has highlighted the opening of its first indoor cultivation facility and has referenced a hybrid greenhouse site in Gainesville. These facilities support the production of cannabis flower that is sold through AYR Wellness dispensaries to registered medical marijuana patients in the state.

The company has announced the launch of flower products under its Kynd brand from the new indoor cultivation facility in Florida. AYR has emphasized expanding product quality and variety for registered patients, referencing a curated library of cannabis genetics and cultivars. The company has also indicated that it operates dispensaries across Florida where patients with a valid medical marijuana recommendation can access its product offerings.

Geographic footprint and core assets

In multiple restructuring-related communications, AYR has identified core assets and going‑concern operations in Florida, New Jersey, Nevada, Ohio, Massachusetts, Pennsylvania and Virginia. These assets include collateral assets and equity interests of specified subsidiaries in those states. The company has indicated that these core assets collectively represent the core operations of the business and are the focus of ongoing sale and transition processes.

AYR’s disclosures reference a plan under which certain senior noteholders will acquire ownership of these core assets through a newly formed acquisition vehicle referred to as NewCo, subject to regulatory approvals and customary closing conditions. While these transactions relate to corporate restructuring, they also underscore the geographic and operational scope of AYR’s core cannabis business.

Restructuring, debt and ownership transition

AYR Wellness has entered into a Restructuring Support Agreement (RSA) with an ad hoc committee of consenting senior noteholders holding a supermajority of its senior notes. The RSA outlines a process that combines an Article 9 sale of collateral assets with an orderly sale and/or wind‑down of remaining assets. The company has stated that this plan is intended to support the continued operation and orderly transition of its core business under new ownership.

As part of this process, AYR has described an Article 9 public foreclosure auction conducted by a collateral trustee on behalf of senior noteholders. The credit bid submitted by senior noteholders was deemed the successful bid to acquire certain collateral assets and equity interests of specified subsidiaries in several U.S. states. AYR has indicated that, following the auction, it expects to execute a Master Purchase Agreement to begin seeking regulatory approvals to transfer ownership of these assets to NewCo.

The company has also disclosed a senior secured bridge term loan facility of up to US$50 million, referred to as the Bridge Facility, provided by certain lenders associated with its senior notes. According to AYR, this facility is intended to support ongoing operations, fund the Article 9 sale process, and facilitate the orderly transition of its core business and wind‑down of non‑core assets, subject to specified budgets, covenants and milestones.

Wind‑down of corporate parent and CCAA proceedings

AYR Wellness has announced the initiation of proceedings under the Companies’ Creditors Arrangement Act (CCAA) in the Supreme Court of British Columbia. The company has stated that these CCAA proceedings are part of its restructuring process and are intended to facilitate an orderly, court‑supervised wind‑down of the existing AYR corporate parent entity. AYR has also indicated that it expects to request the appointment of a licensed insolvency trustee to act as monitor during this process.

In connection with the restructuring and wind‑down, AYR has reported leadership changes, including the appointment of an interim Chief Executive Officer of the corporate parent to finalize the orderly wind‑down, and the planned transition of leadership roles at NewCo. Public statements from AYR emphasize that, during the restructuring and sale process, the company intends to continue operating its core assets in the ordinary course, subject to the terms of the Master Purchase Agreement and other restructuring documents.

Financial reporting and non‑GAAP measures

AYR Wellness files reports as a foreign issuer with the U.S. Securities and Exchange Commission, including Form 6‑K current reports that furnish news releases and material change reports. The company has announced the filing of unaudited interim condensed consolidated financial statements and related Management’s Discussion and Analysis (MD&A) for specific reporting periods. These materials are made available under the company’s profile on SEDAR+ and on the SEC’s EDGAR system.

In its communications, AYR explains that it uses certain non‑GAAP financial measures to evaluate performance and manage its capital structure. The company references measures such as Adjusted EBITDA and Adjusted Gross Profit, which are defined and reconciled to the most directly comparable GAAP measures in its MD&A. AYR notes that these non‑GAAP measures are intended to provide additional insight into the performance of its core businesses from management’s perspective, while cautioning that such measures do not have standardized meanings and may not be comparable to similar measures used by other issuers.

Status and historical context

Based on the company’s own news releases, AYR Wellness is undergoing a significant capital structure restructuring, including the RSA, Article 9 sale process, Bridge Facility, and CCAA proceedings. The company has described a plan to transition its core assets to NewCo owned by certain senior noteholders, while pursuing a court‑supervised wind‑down and liquidation of the existing corporate parent and non‑core assets. These disclosures provide important context for understanding AYRWF as a security linked to a corporate entity in restructuring and wind‑down, rather than a traditional going‑concern growth profile.

Investors reviewing AYRWF and AYR Wellness Inc. may wish to consult the company’s public filings, including Form 6‑Ks, MD&A, and material change reports, for detailed information on the restructuring process, the treatment of senior notes, the Bridge Facility, and the status of CCAA and Article 9 proceedings, as well as the operational performance of the company’s cannabis businesses in its core U.S. markets.

Stock Performance

—
-
-
Last updated: November 4, 2026 at 10:54
-97.9%
Performance 1 year
$432.1K

Ayr Wellness (AYRWF) closed at $0.0037 on July 24, 2026. Over the past 12 months, the price has lost 97.9%.

See what a $1,000 investment in AYRWF would be worth today

Average down calculator for AYRWF

AYRWF Metrics & Rankings

Price returns through July 24, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Financial Highlights

Ayr Wellness generated $463.6M in revenue in FY2024, retaining a 38.1% gross margin, operating income reached -$161.0M (-34.7% operating margin), and net income was -$359.3M, reflecting a -77.5% net profit margin. Diluted earnings per share stood at -$3.24. The company generated $9.6M in operating cash flow. The current ratio was 1.60, measuring current assets divided by current liabilities.

$463.6M
Revenue (FY2024)
-$359.3M
Net Income (FY2024)
$9.6M
Operating Cash Flow

Upcoming Events

APR
10
April 10, 2028 Financial

PIK interest period ends

End of 24-month PIK period for $275M Exit Facility; cash interest begins; senior secured loan with 13.00% interest.
APR
10
April 10, 2031 Financial

Exit Facility maturity

Maturity of $275M Exit Facility; five-year senior secured loan at 13.00% interest. Could require refinancing, affecting leverage.

Ayr Wellness has 2 upcoming scheduled events. The next event, "PIK interest period ends", is scheduled for April 10, 2028 (in 517 days). All of them are financing or capital events, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the AYRWF stock price.

Short Interest History

Last 12 Months

Short interest in Ayr Wellness (AYRWF) currently stands at 1.4 thousand shares, up 0.3% from the previous reporting period, representing 0.0% of the float. Since November 2025, short interest has decreased by 99.8%.

Days to Cover History

Last 12 Months

Days to cover for Ayr Wellness (AYRWF) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 3.6 days.

AYRWF Company Profile & Sector Positioning

Ayr Wellness (AYRWF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing AYRWF often look at related companies in the same sector, including Vibe Growth Corp (VIBEF), Pharmadrug Inc (LMLLF), MultiCorp Intl Inc (MCIC), Green Rain Energy Holding (GREH), and Full Alliance Group Inc (FAGI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AYRWF's relative position within its industry.

Frequently Asked Questions

The current stock price of Ayr Wellness (AYRWF) is $0.0000 as of November 4, 2026.

The market cap of Ayr Wellness (AYRWF) is approximately $432.1K. Learn more about what market capitalization means .

The FY2024 revenue of Ayr Wellness (AYRWF) is $463.6M, from its most recent completed fiscal year.

The FY2024 net income of Ayr Wellness (AYRWF) is -$359.3M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Ayr Wellness (AYRWF) is -$3.24 for FY2024, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Ayr Wellness (AYRWF) is $9.6M for FY2024, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Ayr Wellness (AYRWF) is -77.5% for FY2024, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Ayr Wellness (AYRWF) is -34.7% for FY2024, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Ayr Wellness (AYRWF) is 38.1% for FY2024, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Ayr Wellness (AYRWF), current assets divided by current liabilities, was 1.60 at the end of FY2024, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Ayr Wellness (AYRWF) is $176.7M for FY2024, its most recent completed fiscal year.

The operating income of Ayr Wellness (AYRWF) is -$161.0M for FY2024, its most recent completed fiscal year. Learn about operating income.